如瑞迪博士(RDY)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RDY 如瑞迪博士

盘前交易 01-08 05:58:04 EST

13.68

-0.18

-1.30%

最高13.94	最低13.64	成交量114.27万
今开13.91	昨收13.86	日振幅2.16%
总市值114.18亿	流通市值81.49亿	总股本8.35亿
成交额1,564万	换手率0.19%	流通股本5.96亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"RDY","market":"US","secType":"STK","nameCN":"如瑞迪博士","latestPrice":13.68,"timestamp":1767819600000,"preClose":13.86,"halted":0,"volume":1142658,"delay":0,"floatShares":595667231,"shares":834613760,"eps":0.791383,"marketStatus":"盘前交易","change":-0.18,"latestTime":"01-08 05:58:04 EST","open":13.91,"high":13.94,"low":13.64,"amount":15637755.789018,"amplitude":0.021645,"askPrice":15.5,"askSize":100,"bidPrice":12.5,"bidSize":100,"shortable":3,"etf":0,"ttmEps":0.791383,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1767882600000},"marketStatusCode":1,"adr":1,"adrRate":1,"listingDate":986961600000,"exchange":"NYSE","adjPreClose":13.68,"dividendRate":0.007078,"postHourTrading":{"tag":"盘后","latestPrice":13.68,"preClose":13.68,"latestTime":"17:22 EST","volume":20028,"amount":273983.4612,"timestamp":1767824568858},"volumeRatio":1.2035425710693066,"impliedVol":0.2041,"impliedVolPercentile":0.3012},"requestUrl":"/m/hq/s/RDY","defaultTab":"news","newsList":[{"id":"2553222152","title":"专利即将解禁！如瑞迪博士(RDY.US)司美格鲁肽仿制药将登陆87国市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2553222152","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553222152?lang=zh_cn&edition=full","pubTime":"2025-07-24 09:54","pubTimestamp":1753322093,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，据报道，如瑞迪博士 首席执行官透露，该公司计划自2026年起在87个国家推出诺和诺德减肥药Wegovy活性成分司美格鲁肽的仿制药版本。随着该药物全球专利陆续到期，公司已在多个市场启动注册申报程序。如瑞迪博士的仿制药将率先登陆加拿大、巴西和印度等市场。Israeli特别强调，公司还将在诺和诺德未取得专利保护的国家同步推进上市计划。Israeli指出该药物具有强劲的商业前景，预计司美格鲁肽仿制药可带来数亿美元的增量收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1321332.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"专利即将解禁！如瑞迪博士(RDY.US)司美格鲁肽仿制药将登陆87国市场","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["RDY","BK4007","BK4532","LU0348744763.USD","BK4596","BK4523","BK4557"],"gpt_icon":0},{"id":"1174309415","title":"异动解读 | 如瑞迪博士盘中大跌5.1% 或受业绩利空打压","url":"https://stock-news.laohu8.com/highlight/detail?id=1174309415","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174309415?lang=zh_cn&edition=full","pubTime":"2025-01-23 23:12","pubTimestamp":1737645150,"startTime":"0","endTime":"0","summary":"如瑞迪博士(RDY.US)股价今日盘中出现大幅下跌,最高下挫逾5.1%。\n\n分析指出,这一走低行情或与公司近期财报利空有关。如瑞迪博士近期公布的2025财年第三季度财报显示,公司当季每股收益为0.20美元,与去年同期持平。而公司季度营收则为9.77亿美元,同比增长15.9%。从财报数据来看,公司业绩增长较为乏力,未有亮眼表现,这或令市场失望,减弱了投资者信心,从而引发股价下跌。\n\n不过,由于公司整体经营状况尚可,市场分析人士预计,股价下跌幅度或将受到一定限制。后续公司还需在投资者关系管理方面进一步加强,以稳定投资者信心。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["RDY"],"gpt_icon":0},{"id":"2505012923","title":"如瑞迪博士盘中异动 早盘股价大跌5.10%报14.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505012923","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505012923?lang=zh_cn&edition=full","pubTime":"2025-01-23 23:04","pubTimestamp":1737644694,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日23时04分，如瑞迪博士股票出现异动，股价急速下挫5.10%。截至发稿，该股报14.32美元/股，成交量17.8924万股，换手率0.02%，振幅4.01%。最近的财报数据显示，该股实现营业收入9.57亿美元，净利润1.50亿美元，每股收益0.18美元，毛利5.44亿美元，市盈率18.17倍。机构评级方面，在所有39家参与评级的机构中，41%的券商给予买入建议，33%的券商给予持有建议，26%的券商给予卖出建议。如瑞迪博士股票所在的制药行业中，整体跌幅为0.28%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123230455960e4b27&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123230455960e4b27&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4532","BK4596","BK4557","LU0348744763.USD","RDY","BK4007","BK4523"],"gpt_icon":0},{"id":"1171469608","title":"Dr Reddy's Laboratories 2025年第三季度GAAP每股收益0.20美元，同比0.19美元，销售额9.77亿美元，同比增长8.43亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1171469608","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1171469608?lang=zh_cn&edition=full","pubTime":"2025-01-23 20:50","pubTimestamp":1737636634,"startTime":"0","endTime":"0","summary":"Dr Reddy's Laboratories 2025年第三季度GAAP每股收益为0.20美元，同比为0.19美元，销售额为9.77亿美元，而去年同期为8.43亿美元以上内容来自Benzinga Earnings专栏，原文如下：Dr Reddy's Laboratories Q3 2025 GAAP EPS $0.20 Versus $0.19 YoY, Sales $977.00M Compared To $843M YoY","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Dr Reddy's Laboratories 2025年第三季度GAAP每股收益0.20美元，同比0.19美元，销售额9.77亿美元，同比增长8.43亿美元","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RDY"],"gpt_icon":0},{"id":"2492584179","title":"如瑞迪博士盘中异动 大幅拉升5.15%报15.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492584179","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492584179?lang=zh_cn&edition=full","pubTime":"2024-12-19 22:30","pubTimestamp":1734618633,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日22时30分，如瑞迪博士股票出现波动，股价急速拉升5.15%。截至发稿，该股报15.30美元/股，成交量7.1198万股，换手率0.01%，振幅0.07%。最近的财报数据显示，该股实现营业收入9.57亿美元，净利润1.50亿美元，每股收益0.18美元，毛利5.44亿美元，市盈率19.18倍。如瑞迪博士股票所在的制药行业中，整体涨幅为0.00%。如瑞迪博士公司简介：Dr. Reddy's Laboratories Ltd 总部位于印度，开发和制造销往世界各地的仿制药产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219223033ab849ddf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219223033ab849ddf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4557","RDY","BK4532","LU0348744763.USD","BK4523","BK4596"],"gpt_icon":0},{"id":"2482267393","title":"如瑞迪博士2024财年第三财季实现净利润1.50亿美元，同比减少16.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482267393","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482267393?lang=zh_cn&edition=full","pubTime":"2024-11-11 00:00","pubTimestamp":1731254428,"startTime":"0","endTime":"0","summary":"11月11日，如瑞迪博士公布财报，公告显示公司2024财年第三财季净利润为1.50亿美元，同比减少16.20%；其中营业收入为9.57亿美元，同比增加15.02%，每股基本收益为0.18美元。从资产负债表来看，如瑞迪博士总负债18.70亿美元，其中短期债务4.91亿美元，资产负债比为2.98，流动比率为1.92。机构评级：截至2024年11月11日，当前有37家机构对如瑞迪博士目标价做出预测，其中目标均价为16.22美元，其中最低目标价为12.70美元，最高目标价为19.64美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111000048a229e378&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111000048a229e378&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RDY"],"gpt_icon":0},{"id":"2481998549","title":"如瑞迪博士盘中异动 大幅拉升5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481998549","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481998549?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:30","pubTimestamp":1730903458,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时30分，如瑞迪博士股票出现异动，股价大幅上涨5.03%。截至发稿，该股报15.35美元/股，成交量1.5724万股，换手率0.00%，振幅0.27%。机构评级方面，在所有37家参与评级的机构中，32%的券商给予买入建议，35%的券商给予持有建议，33%的券商给予卖出建议。如瑞迪博士股票所在的制药行业中，整体涨幅为0.00%。如瑞迪博士公司简介：Dr. Reddy's Laboratories Ltd 总部位于印度，开发和制造销往世界各地的仿制药产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223106a21d29d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223106a21d29d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4557","LU0348744763.USD","BK4596","BK4532","BK4523","BK4007","RDY"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.drreddys.com","stockEarnings":[{"period":"1week","weight":-0.0256},{"period":"1month","weight":-0.0151},{"period":"3month","weight":-0.0346},{"period":"6month","weight":-0.0572},{"period":"1year","weight":-0.127},{"period":"ytd","weight":-0.0256}],"compareEarnings":[{"period":"1week","weight":0.0112},{"period":"1month","weight":0.0087},{"period":"3month","weight":0.0274},{"period":"6month","weight":0.1058},{"period":"1year","weight":0.1715},{"period":"ytd","weight":0.0112}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"如瑞迪博士实验室有限公司成立于1984年2月24日，其一体化的全球制药公司通过其三个核心业务部门：全球仿制药分部，医药服务与活性成分部门（PSAI）和专有产品分部，致力于提供价格优惠的新型药物。其全球品牌和无品牌仿制药部分包括处方药和非处方药（OTC）药品经营。公司的医药服务与活性成分部门（PSAI）成由药物成分（API）业务和药学服务定制组成。公司专利产品部分下设生物制药企业，新化学实体业务，分化配方业务及通过promius制药公司运营的皮肤科专业的业务重点企业。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.02054},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.017685},{"month":3,"riseRate":0.708333,"avgChangeRate":0.034592},{"month":4,"riseRate":0.625,"avgChangeRate":0.025232},{"month":5,"riseRate":0.48,"avgChangeRate":-0.002855},{"month":6,"riseRate":0.68,"avgChangeRate":0.048941},{"month":7,"riseRate":0.4,"avgChangeRate":0.006857},{"month":8,"riseRate":0.48,"avgChangeRate":-0.006678},{"month":9,"riseRate":0.6,"avgChangeRate":0.021647},{"month":10,"riseRate":0.56,"avgChangeRate":0.011791},{"month":11,"riseRate":0.68,"avgChangeRate":0.00989},{"month":12,"riseRate":0.52,"avgChangeRate":0.035201}],"exchange":"NYSE","name":"如瑞迪博士","nameEN":"Dr Reddy's Laboratories"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"如瑞迪博士(RDY)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供如瑞迪博士(RDY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"如瑞迪博士,RDY,如瑞迪博士股票,如瑞迪博士股票老虎,如瑞迪博士股票老虎国际,如瑞迪博士行情,如瑞迪博士股票行情,如瑞迪博士股价,如瑞迪博士股市,如瑞迪博士股票价格,如瑞迪博士股票交易,如瑞迪博士股票购买,如瑞迪博士股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"如瑞迪博士(RDY)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供如瑞迪博士(RDY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}